Helix to Present Three-Year Genomic Screening Outcomes at ASHG 2026 Opening Plenary

ConferencePositive

AI Analysis

Summary

Helix will present three-year genomic screening outcomes at the ASHG 2026 Opening Plenary. Additional studies, including on GLP-1 and dementia, draw on the Helix GenoSphere resource of over 620,000 paired EHR, claims, and genomics records.

Outcome Details

Three-year genomic screening outcomes to be presented at the ASHG 2026 Opening Plenary; additional studies span GLP-1 to dementia.

Importance:3/10

Sentiment:

0.30

ASHG 2026genomic screeningprecision medicineHelix GenoSpherereal-world dataGLP-1dementiaconference

Related Companies

$SHWZ

Read the original article

Published by PR Newswire Biotech on October 19, 2026 5:15 PM

Read Original